Reitamo S, Lauerma A I, Förström L
Department of Dermatology, Helsinki University Central Hospital, Finland.
Contact Dermatitis. 1989 Sep;21(3):159-65. doi: 10.1111/j.1600-0536.1989.tb04729.x.
We showed earlier that most patients with contact dermatitis due to corticosteroids show cross-reactions when patch tested with hydrocortisone-17-butyrate (H-17-B). To test whether H-17-B could be used for detecting topical corticosteroid allergy, we screened patients undergoing routine patch testing with H-17-B. Patients with clearly allergic or doubtful/mildly irritant patch test reactions to H-17-B, and with a history suggesting topical corticosteroid allergy, were further tested with a large panel of steroid preparations. 20 out of 4039 patients (0.5%) showed definite allergic test reactions to corticosteroids. A further 165 patients with clinically suspected corticosteroid allergy were directly tested with a panel of steroid preparations; 14 patients showed positive patch test reactions. Altogether, 33 out of 34 patients with corticosteroid allergy had positive test reactions to H-17-B. Inclusion of 1.0% H-17-B in ethanol in the standard patch test series improves the diagnosis of topical corticosteroid hypersensitivity.
我们之前的研究表明,大多数因皮质类固醇引起接触性皮炎的患者在使用丁酸氢化可的松(H-17-B)进行斑贴试验时会出现交叉反应。为了测试H-17-B是否可用于检测局部皮质类固醇过敏,我们对接受H-17-B常规斑贴试验的患者进行了筛查。对H-17-B斑贴试验反应明确为过敏或可疑/轻度刺激,且有局部皮质类固醇过敏史的患者,进一步用大量类固醇制剂进行检测。4039名患者中有20名(0.5%)对皮质类固醇显示出明确的过敏试验反应。另外165名临床怀疑皮质类固醇过敏的患者直接用一组类固醇制剂进行检测;14名患者斑贴试验反应呈阳性。在34名皮质类固醇过敏患者中,共有33名对H-17-B试验反应呈阳性。在标准斑贴试验系列中加入1.0%乙醇中的H-17-B可改善局部皮质类固醇超敏反应的诊断。